Skip to main content

Table 1 Basic characteristics of included studies

From: Review of outcomes of delayed chest closure following lung transplantation: a meta-analysis

Authors, year

Design

Country

Enrolled year

Quality

NOS

DCC/PCC cohorts, n

Bilateral lung Tx, DCC/PCC, n (%)

Indications for transplantation, n (%)

Type of incision

Indications for DCC, n (%)

Duration of DCC (days, median [range])

Force [6]

Single-center, retrospective

The United States

2003–2005

Good

7

7/21

7(100)/21(100)

DCC: COPD/A1AT, 1(14); CF, 1(14); IPF, 1(14); Sarcoidosis/PH, 3(43); Eisenmenger’s Syndrome, 1(14); PCC: COPD/A1AT, 13(62); CF/ bronchiectasis, 4(19); IPF, 4(19)

Bilateral anterior thoracotomy with or without sternal divisiona

based on cardiac and pulmonary impairment during attempted closurea

5.3 [3–7]

Shigemura [4]

Single-center, retrospective

The United States

2004–2011

Good

8

90/783

90(100)/75(10)

DCC: COPD, 8(9); IPF, 37(41); PPH, 20(22); scleroderma, 15(16); other, 11(12); PCC: COPD, 282(36); IPF, 149(19); PPH, 78(10); scleroderma, 47(6); other, 227(29)

NR

Acute lung edema, 40(44); oversized allografts, 38(42); coagulopathy, 29(32); hemodynamic instability, 18(20)

4.5(mean) [1–18]

Aguila [2]

Single-center, retrospective

The United States

2010–1014

Good

8

67/165

66(99)/161(98)

DCC: COPD, 3(4); ILD, 45(67); CF, 8(12); PH, 3(4); re-transplantation, 4(6); other, 4(6); PCC: COPD, 59(36); ILD, 59(36); CF, 33(20); PH, 4(2); re-transplantation, 4(2); other, 6(4)

bilateral, standard anterior thoracotomy; single, posterolateral thoracotomya

Acute lung edema, oversized allografts, coagulopathy, hemodynamic instabilitya

2

Rafiroiu [5]

Single-center, retrospective

The United States

2009–2016

Good

7

46/46

44(96)/43(93)

DCC: IPF, 20(43); CF, 4(9); re-transplantation, 3(7); other, 19(41); PCC: IPF, 17(37); CF, 9(20); re-transplantation, 3(7); other, 17(37)

DCC: thoracotomy, 1(2); sternotomy, 32(70); clamshell, 13(28); PCC: thoracotomy, 6(13); sternotomy, 25(54); clamshell, 15(33)

Coagulopathy/bleeding, hemodynamic instability, hypoxiaa

3 [2–6.2]

  1. COPD chronic obstructive pulmonary disease/emphysema; A1AT alpha 1 antitrypsin deficiency; CF cystic fibrosis; IPF idiopathic pulmonary fibrosis; PH primary or secondary pulmonary hypertension; PPH primary pulmonary hypertension; ILD interstitial lung disease; NR non-reported
  2. aNumbers of patients are not provided